دورية أكاديمية

Respiratory syncytial virus entry mechanism in host cells: A general overview.

التفاصيل البيبلوغرافية
العنوان: Respiratory syncytial virus entry mechanism in host cells: A general overview.
المؤلفون: Cadena-Cruz C; División Ciencias de la Salud, Universidad del Norte Barranquilla, Barranquilla, Colombia.; Facultad de Ciencias de la Salud, Programa de Medicina, Universidad Libre Seccional Barranquilla, Barranquilla, Colombia., Villarreal Camacho JL; Facultad de Ciencias de la Salud, Programa de Medicina, Universidad Libre Seccional Barranquilla, Barranquilla, Colombia., De Ávila-Arias M; División Ciencias de la Salud, Universidad del Norte Barranquilla, Barranquilla, Colombia., Hurtado-Gomez L; División Ciencias de la Salud, Universidad del Norte Barranquilla, Barranquilla, Colombia., Rodriguez A; División Ciencias de la Salud, Universidad del Norte Barranquilla, Barranquilla, Colombia., San-Juan-Vergara H; División Ciencias de la Salud, Universidad del Norte Barranquilla, Barranquilla, Colombia.
المصدر: Molecular microbiology [Mol Microbiol] 2023 Sep; Vol. 120 (3), pp. 341-350. Date of Electronic Publication: 2023 Aug 03.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 8712028 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2958 (Electronic) Linking ISSN: 0950382X NLM ISO Abbreviation: Mol Microbiol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Oxford, OX ; Boston, MA : Blackwell Scientific Publications, c1987-
مواضيع طبية MeSH: Respiratory Syncytial Virus, Human*/metabolism , Respiratory Syncytial Virus Infections*, Infant, Newborn ; Humans ; Aged ; Antibodies, Neutralizing ; Viral Fusion Proteins/metabolism
مستخلص: Respiratory syncytial virus (RSV) is a virus that causes acute respiratory infections in neonates and older adults. To infect host cells, the attachment glycoprotein (G) interacts with a cell surface receptor. This interaction determines the specific cell types that are susceptible to infection. RSV possesses a type I fusion protein F. Type I fusion proteins are metastable when rearrangement of the prefusion F occurs; the fusion peptide is exposed transforming the protein into postfusion form. The transition between the prefusion form and its postfusion form facilitates the viral envelope and the host cell membrane to fuse, enabling the virus to enter the host cell. Understanding the entry mechanism employed by RSV is crucial for developing effective antiviral therapies. In this review, we will discuss the various types of viral fusion proteins and explore the potential entry mechanisms utilized by RSV. A deeper understanding of these mechanisms will provide valuable insights for the development of novel approaches to treat RSV infections.
(© 2023 John Wiley & Sons Ltd.)
References: Aimon, S., Callan-Jones, A., Berthaud, A., Pinot, M., Toombes, G.E.S. & Bassereau, P. (2014) Membrane shape modulates transmembrane protein distribution. Developmental Cell, 28(2), 212-218.
Albertini, A.A.V., Baquero, E., Ferlin, A. & Gaudin, Y. (2012) Molecular and cellular aspects of rhabdovirus entry. Viruses, 4(1), 117-139.
Alonas, E., Lifland, A.W., Gudheti, M., Vanover, D., Jung, J., Zurla, C. et al. (2014) Combining single RNA sensitive probes with subdiffraction-limited and live-cell imaging enables the characterization of virus dynamics in cells. ACS Nano, 8(1), 302-315.
Antonny, B., Burd, C., De Camilli, P., Chen, E., Daumke, O., Faelber, K. et al. (2016) Membrane fission by dynamin: what we know and what we need to know. The EMBO Journal, 35(21), 2270-2284.
Backovic, M. & Jardetzky, T.S. (2011) Class III viral membrane fusion proteins. In: Dittmar, T. & Zänker, K.S. (Eds.) Cell fusion in health and disease (Advances in Experimental Medicine and Biology, Vol. 950) [Internet]. Dordrecht: Springer Netherlands, pp. 91-101. Available from: https://doi.org/10.1007/978-94-007-0782-5_3 [Accessed 23rd May 2023].
Barbosa, J., Parra, B., Alarcón, L., Quiñones, F.I., López, E. & Franco, M.A. (2018) Prevalencia y periodicidad del virus sincitial respiratorio en Colombia. Revista de la Real Academia de Ciencias Exactas, Fisicas y Naturales-Serie A, 41(161), 435.
Barrow, E., Nicola, A.V. & Liu, J. (2013) Multiscale perspectives of virus entry via endocytosis. Virology Journal, 10(1), 177.
Behera, A.K., Matsuse, H., Kumar, M., Kong, X., Lockey, R.F. & Mohapatra, S.S. (2001 Jan) Blocking intercellular adhesion molecule-1 on human epithelial cells decreases respiratory syncytial virus infection. Biochemical and Biophysical Research Communications, 280(1), 188-195.
Benton, D.J., Nans, A., Calder, L.J., Turner, J., Neu, U., Lin, Y.P. et al. (2018) Influenza hemagglutinin membrane anchor. Proceedings of the National Academy of Sciences, 115(40), 10112-10117.
Bergeron, H.C., Murray, J., Nuñez Castrejon, A.M., DuBois, R.M. & Tripp, R.A. (2021) Respiratory syncytial virus (RSV) G protein vaccines with central conserved domain mutations induce CX3C-CX3CR1 blocking antibodies. Viruses, 13(2), 352.
Borochova, K., Niespodziana, K., Focke-Tejkl, M., Hofer, G., Keller, W. & Valenta, R. (2021) Dissociation of the respiratory syncytial virus F protein-specific human IgG, IgA and IgM response. Scientific Reports, 1(1), 3551.
Böttcher-Friebertshäuser, E., Freuer, C., Sielaff, F., Schmidt, S., Eickmann, M., Uhlendorff, J. et al. (2010) Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors. Journal of Virology, 84(11), 5605-5614.
Bowman, M.C., Smallwood, S. & Moyer, S.A. (1999) Dissection of individual functions of the Sendai virus phosphoprotein in transcription. Journal of Virology, 73(8), 6474-6483.
Cao, D., Gao, Y., Roesler, C., Rice, S., D'Cunha, P., Zhuang, L. et al. (2020) Cryo-EM structure of the respiratory syncytial virus RNA polymerase. Nature Communications, 11(1), 368.
Chirkova, T., Lin, S., Oomens, A.G.P., Gaston, K.A., Boyoglu-Barnum, S., Meng, J. et al. (2015) CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells. The Journal of General Virology, 96(9), 2543-2556.
Collins, P.L., Fearns, R. & Graham, B.S. (2013) Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease. In: Anderson, L.J. & Graham, B.S. (Eds.) Challenges and opportunities for respiratory syncytial virus vaccines (Current Topics in Microbiology and Immunology, Vol. 372) [Internet]. Berlin, Heidelberg: Springer Berlin Heidelberg, pp. 3-38. Available from: https://doi.org/10.1007/978-3-642-38919-1_1 [Accessed 22 May 2023].
Collins, P.L. & Melero, J.A. (2011) Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Research, 162(1-2), 80-99.
Cosset, F.L. & Lavillette, D. (2011) Cell entry of enveloped viruses. In: Advances in genetics [Internet]. Lyon: Elsevier, pp. 121-183 https://linkinghub.elsevier.com/retrieve/pii/B9780123808608000045 [Accessed 2023 May 22].
Crank, M.C., Ruckwardt, T.J., Chen, M., Morabito, K.M., Phung, E., Costner, P.J. et al. (2019) A proof of concept for structure-based vaccine design targeting RSV in humans. Science, 365(6452), 505-509.
Cullen, L.M., Schmidt, M.R. & Morrison, T.G. (2017) The importance of RSV F protein conformation in VLPs in stimulation of neutralizing antibody titers in mice previously infected with RSV. Human Vaccines & Immunotherapeutics, 13(12), 2814-2823.
da Silva, E.F., Antunes Fernandes, K.H., Diedrich, D., Gotardi, J., Freire Franco, M.S., de Paula, T. et al. (2022) New triazole-substituted triterpene derivatives exhibiting anti-RSV activity: synthesis, biological evaluation, and molecular modeling. Beilstein Journal of Organic Chemistry, 18, 1524-1531.
Dimitrov, D.S. (2004 Feb) Virus entry: molecular mechanisms and biomedical applications. Nature Reviews. Microbiology, 2(2), 109-122.
Doherty, G.J. & McMahon, H.T. (2009) Mechanisms of endocytosis. Annual Review of Biochemistry, 78(1), 857-902.
Fearns, R. & Collins, P.L. (1999) Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription. Journal of Virology, 73(7), 5852-5864.
Ferlin, A., Raux, H., Baquero, E., Lepault, J. & Gaudin, Y. (2014) Characterization of pH-sensitive molecular switches that trigger the structural transition of vesicular stomatitis virus glycoprotein from the Postfusion state toward the prefusion state. Lyles DS, editor. Journal of Virology, 88(22), 13396-13409.
Fuentes, S., Tran, K.C., Luthra, P., Teng, M.N. & He, B. (2007) Function of the respiratory syncytial virus small hydrophobic protein. Journal of Virology, 81(15), 8361-8366.
Gamba-Sanchez, N., Rodriguez-Martinez, C.E. & Sossa-Briceño, M.P. (2016) Epidemic activity of respiratory syncytial virus is related to temperature and rainfall in equatorial tropical countries. Epidemiology and Infection, 144(10), 2057-2063.
Gambin, Y., Ariotti, N., McMahon, K.A., Bastiani, M., Sierecki, E., Kovtun, O. et al. (2014) Single-molecule analysis reveals self assembly and nanoscale segregation of two distinct cavin subcomplexes on caveolae. eLife, 3, e01434.
Gan, S.W., Tan, E., Lin, X., Yu, D., Wang, J., Tan, G.M.Y. et al. (2012) The small hydrophobic protein of the human respiratory syncytial virus forms pentameric ion channels. The Journal of Biological Chemistry, 287(29), 24671-24689.
Garcia-Moro, E., Zhang, J., Calder, L.J., Brown, N.R., Gamblin, S.J., Skehel, J.J. et al. (2022) Reversible structural changes in the influenza hemagglutinin precursor at membrane fusion pH. Proceedings of the National Academy of Sciences, 119(33), e2208011119.
Gilman MSA, Furmanova-Hollenstein P, Pascual G, van ‘t Wout AB, Langedijk JPM, McLellan JS. Transient opening of trimeric prefusion RSV F proteins. Nature Communications 2019;10(1):2105.
Gonzales, T., Bergamasco, A., Cristarella, T., Goyer, C., Wojdyla, M., Oladapo, A. et al. (2022) Effectiveness and safety of palivizumab for the prevention of serious lower respiratory tract infection caused by respiratory syncytial virus: A systematic review. American Journal of Perinatology, a-1990-2633. Available from: https://doi.org/10.1055/a-1990-2633.
Griffiths, C.D., Bilawchuk, L.M., McDonough, J.E., Jamieson, K.C., Elawar, F., Cen, Y. et al. (2020 Jul 23) IGF1R is an entry receptor for respiratory syncytial virus. Nature, 583(7817), 615-619.
Hallak, L.K., Kwilas, S.A. & Peeples, M.E. (2007) Interaction between respiratory syncytial virus and glycosaminoglycans, including heparan sulfate. In: Sugrue, R.J. & Walker, J.M. (Eds.) Glycovirology protocols (Methods in Molecular Biology, Vol. 379) [Internet]. Totowa, NJ: Humana Press, pp. 15-34. Available from: https://doi.org/10.1007/978-1-59745-393-6_2 [Accessed 22 May 2023].
Hara, K., Yaita, K., Khamrin, P., Kumthip, K., Kashiwagi, T., Eléouët, J.F. et al. (2020) A small fragmented P protein of respiratory syncytial virus inhibits virus infection by targeting P protein. The Journal of General Virology, 101(1), 21-32.
Harrison, S.C. (2015) Viral membrane fusion. Virology, 479-480, 498-507.
Henley, J.R., Krueger, E.W.A., Oswald, B.J. & McNiven, M.A. (1998) Dynamin-mediated internalization of caveolae. The Journal of Cell Biology, 141(1), 85-99.
Holkar, S.S., Kamerkar, S.C. & Pucadyil, T.J. (2015) Spatial control of Epsin-induced Clathrin assembly by membrane curvature. The Journal of Biological Chemistry, 290(23), 14267-14276.
Hosseini, S.S., Ghasemian, E., Jamaati, H., Tabaraie, B., Amini, Z. & Cox, K. (2015) Association between respiratory viruses and exacerbation of COPD: a case-control study. Infectious Diseases, 47(8), 523-529.
Hotard, A.L., Lee, S., Currier, M.G., Crowe, J.E., Sakamoto, K., Newcomb, D.C. et al. (2015) Identification of residues in the human respiratory syncytial virus fusion protein that modulate fusion activity and pathogenesis. Lyles DS, editor. Journal of Virology, 89(1), 512-522.
Jeong KI, Piepenhagen PA, Kishko M, DiNapoli JM, Groppo RP, Zhang L, et al. CX3CR1 is expressed in differentiated human ciliated airway cells and Co-localizes with respiratory syncytial virus on cilia in a G protein-dependent manner. Tregoning JS, editor. PLOS One. 2015;10(6):e0130517.
Johnson SM, McNally BA, Ioannidis I, Flano E, Teng MN, Oomens AG, et al. Respiratory syncytial virus uses CX3CR1 as a receptor on primary human airway epithelial cultures. Heise MT, editor. PLOS Pathogens. 2015;11(12):e1005318.
Joyce, M.G., Bao, A., Chen, M., Georgiev, I.S., Ou, L., Bylund, T. et al. (2019) Crystal structure and immunogenicity of the DS-Cav1-stabilized fusion glycoprotein from respiratory syncytial virus subtype B. Pathogens and Immunity, 4(2), 294-323.
Kahn, J.S., Schnell, M.J., Buonocore, L. & Rose, J.K. (1999) Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion. Virology, 254(1), 81-91.
Kaksonen, M. & Roux, A. (2018) Mechanisms of clathrin-mediated endocytosis. Nature Reviews. Molecular Cell Biology, 19(5), 313-326.
Kauvar, L.M., Harcourt, J.L., Haynes, L.M. & Tripp, R.A. (2010) Therapeutic targeting of respiratory syncytial virus G-protein. Immunotherapy, 2(5), 655-661.
Kielian, M. & Rey, F.A. (2006) Virus membrane-fusion proteins: more than one way to make a hairpin. Nature Reviews. Microbiology, 4(1), 67-76.
King, T., Mejias, A., Ramilo, O. & Peeples, M.E. (2021) The larger attachment glycoprotein of respiratory syncytial virus produced in primary human bronchial epithelial cultures reduces infectivity for cell lines. Pietschmann T, editor. PLOS Pathogens, 17(4), e1009469.
Kokturk, N., Bozdayi, G., Yilmaz, S., Doğan, B., Gulbahar, O., Rota, S. et al. (2015) Detection of adenovirus and respiratory syncytial virus in patients with chronic obstructive pulmonary disease: exacerbation versus stable condition. Molecular Medicine Reports, 12(2), 3039-3046.
Kolokoltsov, A.A., Deniger, D., Fleming, E.H., Roberts, N.J., Karpilow, J.M. & Davey, R.A. (2007) Small interfering RNA profiling reveals key role of Clathrin-mediated endocytosis and early endosome formation for infection by respiratory syncytial virus. Journal of Virology, 81(14), 7786-7800.
Kondo, N., Marin, M., Kim, J.H., Desai, T.M. & Melikyan, G.B. (2015) Distinct requirements for HIV-cell fusion and HIV-mediated cell-cell fusion. The Journal of Biological Chemistry, 290(10), 6558-6573.
Krzyzaniak, M.A., Zumstein, M.T., Gerez, J.A., Picotti, P. & Helenius, A. (2013) Host cell entry of respiratory syncytial virus involves macropinocytosis followed by proteolytic activation of the F protein. Pekosz A, editor. PLoS Pathogens, 9(4), e1003309.
Lamaze, C., Tardif, N., Dewulf, M., Vassilopoulos, S. & Blouin, C.M. (2017) The caveolae dress code: structure and signaling. Current Opinion in Cell Biology, 47, 117-125.
Lozada, C., Barlow, T.M.A., Gonzalez, S., Lubin-Germain, N. & Ballet, S. (2021) Identification and characteristics of fusion peptides derived from enveloped viruses. Frontiers in Chemistry, 9, 689006.
Lu, B., Ma, C.H., Brazas, R. & Jin, H. (2002) The major phosphorylation sites of the respiratory syncytial virus phosphoprotein are dispensable for virus replication In vitro. Journal of Virology, 76(21), 10776-10784.
Luo, J., Qin, H., Lei, L., Lou, W., Li, R. & Pan, Z. (2022) Virus-like particles containing a prefusion-stabilized F protein induce a balanced immune response and confer protection against respiratory syncytial virus infection in mice. Frontiers in Immunology, 13), 1054005.
Lv, C., Yang, C., Ding, D., Sun, Y., Wang, R., Han, D. et al. (2019) Endocytic pathways and intracellular transport of aptamer-drug conjugates in live cells monitored by single-particle tracking. Analytical Chemistry, 91(21), 13818-13823.
Malhotra, R., Ward, M., Bright, H., Priest, R., Foster, M.R., Hurle, M. et al. (2003) Isolation and characterisation of potential respiratory syncytial virus receptor(s) on epithelial cells. Microbes and Infection, 5(2), 123-133.
Marsh, M. & Helenius, A. (2006) Virus entry: open sesame. Cell, 124(4), 729-740.
Más V, Melero JA. Entry of enveloped viruses into host cells: membrane fusion. In: Mateu MG, editor. Structure and physics of viruses (Subcellular Biochemistry, Vol. 68 [Internet]). Dordrecht: Springer Netherlands; 2013. pp. 467-87. https://doi.org/10.1007/978-94-007-6552-8_16 [Accessed 23 May 2023].
Mas, V., Nair, H., Campbell, H., Melero, J.A. & Williams, T.C. (2018) Antigenic and sequence variability of the human respiratory syncytial virus F glycoprotein compared to related viruses in a comprehensive dataset. Vaccine, 36(45), 6660-6673.
Mastrangelo, P. & Hegele, R. (2013) RSV fusion: time for a new model. Viruses, 5(3), 873-885.
Matthaeus, C. & Taraska, J.W. (2021) Energy and dynamics of caveolae trafficking. Frontiers in Cell and Development Biology, 8, 614472.
McLellan, J.S., Chen, M., Joyce, M.G., Sastry, M., Stewart-Jones, G.B.E., Yang, Y. et al. (2013) Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. Science, 342(6158), 592-598.
McLellan, J.S., Chen, M., Leung, S., Graepel, K.W., Du, X., Yang, Y. et al. (2013) Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody. Science, 340(6136), 1113-1117.
McLellan, J.S., Ray, W.C. & Peeples, M.E. (2013) Structure and function of respiratory syncytial virus surface glycoproteins. In: Anderson, L.J. & Graham, B.S. (Eds.) Challenges and opportunities for respiratory syncytial virus vaccines (Current Topics in Microbiology and Immunology, Vol. 372 [Internet]). Berlin, Heidelberg: Springer Berlin Heidelberg, pp. 83-104. Available from: https://doi.org/10.1007/978-3-642-38919-1_4 [Accessed 22 May 2023].
McMahon, H.T. & Boucrot, E. (2015) Membrane curvature at a glance. Journal of Cell Science, 128(6), 1065-1070.
Mercer, J., Schelhaas, M. & Helenius, A. (2010) Virus entry by endocytosis. Annual Review of Biochemistry, 79(1), 803-833.
Modis, Y. & Class, I.I. (2013) Fusion proteins. In: Pöhlmann, S. & Simmons, G. (Eds.) Viral entry into host cells (Advances in Experimental Medicine and Biology, Vol. 790) [Internet]. New York, NY: Springer New York, pp. 150-166. Available from: https://doi.org/10.1007/978-1-4614-7651-1_8 [Accessed 23 May 2023].
Papi, A., Ison, M.G., Langley, J.M., Lee, D.G., Leroux-Roels, I., Martinon-Torres, F. et al. (2023) Respiratory syncytial virus prefusion F protein vaccine in older adults. The New England Journal of Medicine, 388(7), 595-608.
Paraan, M., Mendez, J., Sharum, S., Kurtin, D., He, H. & Stagg, S.M. (2020) The structures of natively assembled clathrin-coated vesicles. Science Advances, 6(30), eaba8397.
Piñeros, J.G., Baquero, H., Bastidas, J., García, J., Ovalle, O., Patiño, C.M. et al. (2013) Respiratory syncytial virus infection as a cause of hospitalization in population under 1 year in Colombia. Jornal de Pediatria, 89(6), 544-548.
Rahman, M.M. & Williams, S.J. (2021) Membrane tension may define the deadliest virus infection. Colloid and Interface Science Communications, 40, 100338.
Rey, F.A. & Lok, S.M. (2018) Common features of enveloped viruses and implications for immunogen design for next-generation vaccines. Cell, 172(6), 1319-1334.
San-Juan-Vergara, H., Sampayo-Escobar, V., Reyes, N., Cha, B., Pacheco-Lugo, L., Wong, T. et al. (2012) Cholesterol-rich microdomains as docking platforms for respiratory syncytial virus in Normal human bronchial epithelial cells. Journal of Virology, 86(3), 1832-1843.
Sedeyn, K., Schepens, B. & Saelens, X. (2019) Respiratory syncytial virus nonstructural proteins 1 and 2: exceptional disrupters of innate immune responses. Hobman TC, editor. PLOS Pathogens, 15(10), e1007984.
Shang, Z., Tan, S. & Ma, D. (2021) Respiratory syncytial virus: from pathogenesis to potential therapeutic strategies. International Journal of Biological Sciences, 17(14), 4073-4091.
Simões, E.A.F., Center, K.J., Tita, A.T.N., Swanson, K.A., Radley, D., Houghton, J. et al. (2022) Prefusion F protein-based respiratory syncytial virus immunization in pregnancy. The New England Journal of Medicine, 386(17), 1615-1626.
Song, S., Zhang, Y., Ding, T., Ji, N. & Zhao, H. (2021) The dual role of macropinocytosis in cancers: promoting growth and inducing methuosis to participate in anticancer therapies as targets. Frontiers in Oncology, 10, 570108.
Srinivasakumar, N., Ogra, P.L. & Flanagan, T.D. (1991) Characteristics of fusion of respiratory syncytial virus with HEp-2 cells as measured by R18 fluorescence dequenching assay. Journal of Virology, 65(8), 4063-4069.
Stoeber, M., Schellenberger, P., Siebert, C.A., Leyrat, C., Helenius, A. & Grünewald, K. (2016) Model for the architecture of caveolae based on a flexible, net-like assembly of Cavin1 and Caveolin discs. Proceedings of the National Academy of Sciences [Internet], 113(50), E8069-E8078. Available from: https://doi.org/10.1073/pnas.1616838113 [Accessed 23 May 2023].
Swanson, J.A. & Watts, C. (1995) Macropinocytosis. Trends in Cell Biology, 5(11), 424-428.
Swanson, K.A., Settembre, E.C., Shaw, C.A., Dey, A.K., Rappuoli, R., Mandl, C.W. et al. (2011) Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers. Proceedings of the National Academy of Sciences, 108(23), 9619-9624.
Tayyari, F., Marchant, D., Moraes, T.J., Duan, W., Mastrangelo, P. & Hegele, R.G. (2011) Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nature Medicine, 17(9), 1132-1135.
Techaarpornkul, S., Collins, P.L. & Peeples, M.E. (2002) Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus. Virology, 294(2), 296-304.
Thornhill, E.M. & Verhoeven, D. (2020) Respiratory syncytial virus's non-structural proteins: masters of interference. Frontiers in Cellular and Infection Microbiology, 10, 225.
Tiong-Yip, C.L., Aschenbrenner, L., Johnson, K.D., McLaughlin, R.E., Fan, J., Challa, S. et al. (2014) Characterization of a respiratory syncytial virus L protein inhibitor. Antimicrobial Agents and Chemotherapy, 58(7), 3867-3873.
Tran, T.L., Castagné, N., Dubosclard, V., Noinville, S., Koch, E., Moudjou, M. et al. (2009) The respiratory syncytial virus M2-1 protein forms tetramers and interacts with RNA and P in a competitive manner. Journal of Virology, 83(13), 6363-6374.
Triantafilou, K., Kar, S., Vakakis, E., Kotecha, S. & Triantafilou, M. (2013) Human respiratory syncytial virus viroporin SH: a viral recognition pathway used by the host to signal inflammasome activation. Thorax, 68(1), 66-75.
Tripp, R.A., Dakhama, A., Jones, L.P., Barskey, A., Gelfand, E.W. & Anderson, L.J. (2003) The G glycoprotein of respiratory syncytial virus depresses respiratory rates through the CX3C motif and substance P. Journal of Virology, 77(11), 6580-6584.
Tripp, R.A., Jones, L.P., Haynes, L.M., Zheng, H., Murphy, P.M. & Anderson, L.J. (2001) CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nature Immunology, 2(8), 732-738.
van Wilgenburg, B., Moore, M.D., James, W.S. & Cowley, S.A. (2014) The productive entry pathway of HIV-1 in macrophages is dependent on endocytosis through lipid rafts containing CD4. Darlix JLEPH, editor. PLoS ONE, 9(1), e86071.
White, J.M., Delos, S.E., Brecher, M. & Schornberg, K. (2008) Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Critical Reviews in Biochemistry and Molecular Biology, 43(3), 189-219.
Willy, N.M., Ferguson, J.P., Akatay, A., Huber, S., Djakbarova, U., Silahli, S. et al. (2021) De novo endocytic clathrin coats develop curvature at early stages of their formation. Developmental Cell, 56(22), 3146-3159.e5.
Wisskirchen, K., Lucifora, J., Michler, T. & Protzer, U. (2014) New pharmacological strategies to fight enveloped viruses. Trends in Pharmacological Sciences, 35(9), 470-478.
Yamauchi, Y. & Helenius, A. (2013) Virus entry at a glance. Journal of Cell Science, 126, 1289-1295.
فهرسة مساهمة: Keywords: endocytosis; fusion proteins; mechanism of entry; plasma membrane; respiratory syncytial virus; viral fusion
المشرفين على المادة: 0 (Antibodies, Neutralizing)
0 (Viral Fusion Proteins)
تواريخ الأحداث: Date Created: 20230804 Date Completed: 20230925 Latest Revision: 20230925
رمز التحديث: 20230925
DOI: 10.1111/mmi.15133
PMID: 37537859
قاعدة البيانات: MEDLINE
الوصف
تدمد:1365-2958
DOI:10.1111/mmi.15133